vs

Side-by-side financial comparison of Local Bounti Corporation (LOCL) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Local Bounti Corporation is the larger business by last-quarter revenue ($12.5M vs $7.0M, roughly 1.8× Lakeside Holding Ltd). Lakeside Holding Ltd runs the higher net margin — -22.6% vs -69.8%, a 47.2% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 23.7%).

Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

LOCL vs LSH — Head-to-Head

Bigger by revenue
LOCL
LOCL
1.8× larger
LOCL
$12.5M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+71.3% gap
LSH
95.0%
23.7%
LOCL
Higher net margin
LSH
LSH
47.2% more per $
LSH
-22.6%
-69.8%
LOCL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LOCL
LOCL
LSH
LSH
Revenue
$12.5M
$7.0M
Net Profit
$-8.7M
$-1.6M
Gross Margin
12.2%
27.2%
Operating Margin
-106.1%
-21.3%
Net Margin
-69.8%
-22.6%
Revenue YoY
23.7%
95.0%
Net Profit YoY
76.0%
18.7%
EPS (diluted)
$1.52
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOCL
LOCL
LSH
LSH
Q4 25
$12.5M
$7.0M
Q3 25
$12.2M
$6.1M
Q2 25
$12.1M
$6.3M
Q1 25
$11.6M
$3.8M
Q4 24
$10.1M
$3.6M
Q3 24
$10.2M
$4.1M
Q2 24
$9.4M
Q1 24
$8.4M
Net Profit
LOCL
LOCL
LSH
LSH
Q4 25
$-8.7M
$-1.6M
Q3 25
$-26.4M
$-1.4M
Q2 25
$-21.6M
$-893.1K
Q1 25
$-37.7M
$-1.1M
Q4 24
$-36.3M
$-1.9M
Q3 24
$-34.3M
$-1.3M
Q2 24
$-25.3M
Q1 24
$-24.1M
Gross Margin
LOCL
LOCL
LSH
LSH
Q4 25
12.2%
27.2%
Q3 25
11.5%
18.2%
Q2 25
12.2%
26.7%
Q1 25
12.6%
18.8%
Q4 24
5.4%
-1.2%
Q3 24
13.8%
12.8%
Q2 24
14.3%
Q1 24
9.4%
Operating Margin
LOCL
LOCL
LSH
LSH
Q4 25
-106.1%
-21.3%
Q3 25
-149.4%
-20.8%
Q2 25
-127.7%
-8.9%
Q1 25
-135.6%
-28.2%
Q4 24
-166.6%
-55.6%
Q3 24
-176.0%
-32.5%
Q2 24
-146.8%
Q1 24
-122.9%
Net Margin
LOCL
LOCL
LSH
LSH
Q4 25
-69.8%
-22.6%
Q3 25
-216.6%
-22.2%
Q2 25
-178.3%
-14.2%
Q1 25
-324.6%
-28.2%
Q4 24
-360.1%
-54.1%
Q3 24
-335.2%
-32.7%
Q2 24
-267.6%
Q1 24
-286.9%
EPS (diluted)
LOCL
LOCL
LSH
LSH
Q4 25
$1.52
$-0.08
Q3 25
$-1.18
$-0.09
Q2 25
$-1.63
$-0.11
Q1 25
$-4.32
$-0.14
Q4 24
$-4.24
$-0.26
Q3 24
$-4.01
$-0.18
Q2 24
$-3.00
Q1 24
$-2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOCL
LOCL
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$4.2M
$1.6M
Total DebtLower is stronger
$483.1M
$2.4M
Stockholders' EquityBook value
$-166.2M
$12.2M
Total Assets
$410.5M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOCL
LOCL
LSH
LSH
Q4 25
$4.2M
$1.6M
Q3 25
$6.2M
$4.5M
Q2 25
$5.3M
$5.0M
Q1 25
$18.0M
$1.5M
Q4 24
$937.0K
$1.1M
Q3 24
$317.0K
$2.7M
Q2 24
$9.7M
Q1 24
$8.2M
Total Debt
LOCL
LOCL
LSH
LSH
Q4 25
$483.1M
$2.4M
Q3 25
$484.9M
$2.4M
Q2 25
$478.3M
$1.4M
Q1 25
$480.0M
$774.2K
Q4 24
$436.8M
$784.8K
Q3 24
$398.4M
$589.9K
Q2 24
$374.0M
Q1 24
$329.8M
Stockholders' Equity
LOCL
LOCL
LSH
LSH
Q4 25
$-166.2M
$12.2M
Q3 25
$-158.1M
$7.0M
Q2 25
$-132.7M
$2.8M
Q1 25
$-134.5M
$749.8K
Q4 24
$-100.5M
$1.6M
Q3 24
$-65.6M
$3.6M
Q2 24
$-32.8M
Q1 24
$-9.4M
Total Assets
LOCL
LOCL
LSH
LSH
Q4 25
$410.5M
$24.3M
Q3 25
$417.8M
$18.6M
Q2 25
$426.8M
$14.4M
Q1 25
$447.2M
$9.9M
Q4 24
$428.0M
$9.8M
Q3 24
$430.8M
$10.8M
Q2 24
$438.1M
Q1 24
$413.4M
Debt / Equity
LOCL
LOCL
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LOCL
LOCL
LSH
LSH
Operating Cash FlowLast quarter
$-3.1M
$-453.5K
Free Cash FlowOCF − Capex
$-3.6M
FCF MarginFCF / Revenue
-29.1%
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LOCL
LOCL
LSH
LSH
Q4 25
$-3.1M
$-453.5K
Q3 25
$-8.9M
$-4.0M
Q2 25
$-8.7M
$-483.7K
Q1 25
$-9.6M
$-238.3K
Q4 24
$1.2M
$-530.2K
Q3 24
$-17.2M
$-1.4M
Q2 24
$-4.0M
Q1 24
$-7.1M
Free Cash Flow
LOCL
LOCL
LSH
LSH
Q4 25
$-3.6M
Q3 25
$-10.1M
Q2 25
$-14.6M
$-497.4K
Q1 25
$-14.5M
Q4 24
$-8.6M
$-560.5K
Q3 24
$-30.0M
$-1.4M
Q2 24
$-28.8M
Q1 24
$-42.1M
FCF Margin
LOCL
LOCL
LSH
LSH
Q4 25
-29.1%
Q3 25
-82.8%
Q2 25
-121.0%
-7.9%
Q1 25
-125.1%
Q4 24
-85.3%
-15.6%
Q3 24
-293.1%
-34.5%
Q2 24
-305.4%
Q1 24
-501.8%
Capex Intensity
LOCL
LOCL
LSH
LSH
Q4 25
3.9%
Q3 25
9.7%
Q2 25
48.9%
0.2%
Q1 25
42.8%
0.0%
Q4 24
97.6%
0.8%
Q3 24
125.0%
0.1%
Q2 24
263.0%
Q1 24
417.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LOCL
LOCL

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons